Literature DB >> 583277

Regular character of chromatin degradation in lymphoid tissues after treatment with biological alkylating agents in vivo.

J Matyásová, M Skalka, M Cejková.   

Abstract

The aim of the present study was to reassume the chromatin changes occurring in lymphoid tissues of mice treated with alkylating agents of the nitrogen-mustard type in relation to recent evidence on the nucleosomal organization of chromatin and to our new data on the regular character of chromatin degradation in lymphoid tissues of irradiated mice. DNA was isolated from nuclei at various intervals (1-18 h) after treatment of mice and subjected to gel electrophoresis in polyacrylamide gels. Thymus chromatin from treated mice has been shown to degrade in a regular fashion and to yield discrete DNA fragments, resembling those that originate in lymphoid tissues of irradiated mice or in thymus nuclei digested with micrococcal nuclease in vitro. With increasing interval after treatment higher amounts of smaller DNA fragments appear. Chromatin in spleen cells responds to treatment in a similar way, whilst no degradation in vivo takes place in liver chromatin. Chromatin of LS/BL lymphosarcoma cells in mice treated with alkylating agents or with irradiation suffers from a similar regular degradation. The results stress the significance of the action of liberated or activated endogenous nuclease(s) in the development of chromatin damage in lymphoid cells after treatment with alkylating agents.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 583277

Source DB:  PubMed          Journal:  Folia Biol (Praha)        ISSN: 0015-5500            Impact factor:   0.906


  2 in total

1.  DNA cleavage in chromatin spacer segments by a non-enzymic probe, 1,10-phenanthroline-copper complex.

Authors:  M Skalka; M Cejková
Journal:  Mol Biol Rep       Date:  1985-04       Impact factor: 2.316

2.  Role of anions in the lymphocytolytic action of corticosteroids and fatty acids.

Authors:  A F Burton; W L Dunn
Journal:  Mol Cell Biochem       Date:  1984-09       Impact factor: 3.396

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.